Viatris (VTRS) Inventory Average (2021 - 2026)
Viatris' (VTRS) quarterly Inventory Average came in at $4.0 billion in Q1 2026, little changed year-on-year from $4.0 billion in Q1 2025, and down 2.27% quarter-over-quarter from $4.1 billion in Q4 2025.
Viatris (VTRS) Inventory Average (2021 - 2026) Analysis & Trends
Viatris' Inventory Average history runs 6 years deep, the most recent figure standing at $4.0 billion for Q1 2026.
- On a quarterly basis, Inventory Average changed 0.31% year-over-year to $4.0 billion in Q1 2026; TTM through Mar 2026 was $4.0 billion, a 0.31% change from a year earlier, with the FY2025 full-year figure at $3.9 billion, up 7.23% from the prior year.
- Inventory Average slipped to $4.0 billion in Q1 2026 per VTRS's latest filing, from $4.1 billion in the prior quarter.
- Across five years, Inventory Average topped out at $4.2 billion in Q3 2025 and bottomed at $3.4 billion in Q4 2022.
- The 5-year median for Inventory Average is $3.9 billion (2024), against an average of $3.8 billion.
- Across the five-year window, Inventory Average retreated 25.34% in 2022 and climbed 11.16% in 2024, its largest moves.
- Year by year, Inventory Average stood at $3.4 billion in 2022, then advanced by 3.5% to $3.6 billion in 2023, then grew by 11.16% to $4.0 billion in 2024, then rose by 2.17% to $4.1 billion in 2025, then fell by 2.27% to $4.0 billion in 2026.
- Per Business Quant, the three latest VTRS Inventory Average figures stand at $4.0 billion (Q1 2026), $4.1 billion (Q4 2025), and $4.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 68.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96 Bn |
| Dec 31, 2025 | 4.06 Bn |
| Sep 30, 2025 | 4.19 Bn |
| Jun 30, 2025 | 4.18 Bn |
| Mar 31, 2025 | 3.98 Bn |
| Dec 31, 2024 | 3.97 Bn |
| Sep 30, 2024 | 4.01 Bn |
| Jun 30, 2024 | 3.88 Bn |
| Mar 31, 2024 | 3.65 Bn |
| Dec 31, 2023 | 3.57 Bn |
| Sep 30, 2023 | 3.66 Bn |
| Jun 30, 2023 | 3.65 Bn |
| Mar 31, 2023 | 3.59 Bn |
| Dec 31, 2022 | 3.45 Bn |
| Sep 30, 2022 | 3.50 Bn |
| Jun 30, 2022 | 3.70 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 4.03 Bn |
| Sep 30, 2021 | 4.28 Bn |
| Jun 30, 2021 | 4.71 Bn |